Cargando…
GPR92/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques
AIMS: Oxidative processes and vascular inflammation underlying atherosclerosis lead to an accumulation of lysophosphatidic acid (LPA) molecules in the atheromatous intima. LPA, a platelet-activating component of human atherosclerotic plaques, possibly contributes to atherothrombus formation after pl...
Autores principales: | Khandoga, Anna L., Pandey, Dharmendra, Welsch, Ulrich, Brandl, Richard, Siess, Wolfgang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058733/ https://www.ncbi.nlm.nih.gov/pubmed/21106562 http://dx.doi.org/10.1093/cvr/cvq369 |
Ejemplares similares
-
Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque
por: Dwivedi, Suman, et al.
Publicado: (2010) -
Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015) -
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA(2) in Macrophages
por: Gu, Chun, et al.
Publicado: (2017) -
Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014) -
MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)